Literature DB >> 26403662

Comment on: "Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years".

Christoph-A von Klot1, Axel S Merseburger2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26403662     DOI： 10.1007/s00345-015-1683-4

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  4 in total

Review 1.  The survival benefit of lymph node dissection at the time of removal of kidney, prostate and urothelial carcinomas: what is the evidence?

Authors:  Karim Bensalah; Morgan Roupret; Evanguelos Xylinas; Shahrokh Shariat
Journal:  World J Urol       Date:  2013-04-16       Impact factor: 4.226

2.  Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence.

Authors:  Stephen A Boorjian; R Houston Thompson; Matthew K Tollefson; Laureano J Rangel; Eric J Bergstralh; Michael L Blute; R Jeffrey Karnes
Journal:  Eur Urol       Date:  2011-02-22       Impact factor: 20.096

3.  Removal of limited nodal disease in patients undergoing radical prostatectomy: long-term results confirm a chance for cure.

Authors:  Roland Seiler; Urs E Studer; Konrad Tschan; Pia Bader; Fiona C Burkhard
Journal:  J Urol       Date:  2013-11-18       Impact factor: 7.450

4.  Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer.

Authors:  Ali Afshar-Oromieh; Christian M Zechmann; Anna Malcher; Matthias Eder; Michael Eisenhut; Heinz G Linhart; Tim Holland-Letz; Boris A Hadaschik; Frederik L Giesel; Jürgen Debus; Uwe Haberkorn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-27       Impact factor: 9.236
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.